Harpoon Therapeutics, Inc.
USD23.01
+0.02 (+0.09%)
CEO
Julie M. Eastland
IPO Date
2019-02-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$23.00
Prev. Close
$22.99
Day Low
$22.99
Day High
$23.02
52W Low
$3.11
52W High
$23.21
Market Cap
$0.87B
Volume
6.40M
| -1.5 |
| 31 Dec 2020 | FY | 100.0% | -265.9% | -86.1% | -27.0% | 0.25 | 2.71 | -9.0 |
| 31 Dec 2019 | FY | 100.0% | -900.1% | -55.2% | -29.4% | 0.16 | 6.69 | -6.2 |
| 31 Dec 2018 | FY | 100.0% | -576.1% | 51.2% | -26.7% | 0.00 | 7.55 | -11.8 |
| 31 Dec 2017 | FY | 100.0% | -2377.1% | 62.5% | -52.8% | 0.00 | 4.29 | -7.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 109.2% | -136.0% | -0.22 | 2.15 | -111.8 |
| 6.3 |
| 31 Mar 2023 | Q1 | 87.1% | -140.4% | -1685.2% | -14.9% | 21.83 | 1.45 | -0.6 |
| 31 Dec 2022 | Q4 | 77.7% | -442.0% | -334.8% | -24.5% | 2.96 | 1.04 | -0.3 |
| 30 Sept 2022 | Q3 | 94.8% | -83.7% | -67.4% | -13.6% | 0.65 | 1.28 | -0.7 |
| 30 Jun 2022 | Q2 | 100.0% | -208.3% | -64.9% | -15.9% | 0.43 | 1.62 | -0.9 |
| 31 Mar 2022 | Q1 | 100.0% | -344.2% | -49.1% | -15.3% | 0.29 | 2.00 | -2.0 |
| 31 Dec 2021 | Q4 | 100.0% | -498.3% | -37.1% | -13.9% | 0.21 | 2.33 | -2.9 |
| 30 Sept 2021 | Q3 | 100.0% | -372.0% | -21.7% | -9.6% | 0.16 | 2.82 | -3.9 |
| 30 Jun 2021 | Q2 | 100.0% | -287.2% | -18.4% | -8.5% | 0.14 | 3.21 | -6.7 |